These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 9723304

  • 1. Microemulsion cyclosporine (Neoral) immunosuppression for orthotopic liver transplantation in children reduces hospital stay.
    Arumugam R, Soriano HE, Scheimann AO, Reid BS, Gopalakrishna GS, Barakat O, Ozaki CF, Wood RP.
    Transplant Proc; 1998 Aug; 30(5):1848-9. PubMed ID: 9723304
    [No Abstract] [Full Text] [Related]

  • 2. Conversion from the conventional cyclosporine formulation (Sandimmune) to a new oral microemulsion (Neoral) in stable liver transplant patients.
    Dibo-Cohen JM, Conort O, Conti F, Bernard D, Hazebroucq G, Calmus Y.
    Transplant Proc; 1998 Aug; 30(5):1857. PubMed ID: 9723309
    [No Abstract] [Full Text] [Related]

  • 3. Frequency of switch from cyclosporine to FK 506 before and after Neoral use in pediatric liver transplantation.
    Gridelli B, Colledan M, Lucianetti A, Ulla L, Riva S, Segalin A, Fassati LR, Torre G.
    Transplant Proc; 1998 Aug; 30(5):1861-2. PubMed ID: 9723311
    [No Abstract] [Full Text] [Related]

  • 4. Safety of conversion from cyclosporine Sandimmune to cyclosporine Neoral in stable liver transplant patients.
    Baruch Y, Assy N, Kramsky R, Enat R.
    Transplant Proc; 1998 Aug; 30(5):1852-3. PubMed ID: 9723306
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Results of conversion from Sandimmune to Neoral in stable pediatric liver transplant recipients after two years.
    Dunn SP, Falkenstein K, Pierson A, Cooney GF.
    Transplant Proc; 1998 Aug; 30(5):1962-3. PubMed ID: 9723353
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Potential role of Neoral in pediatric liver transplantation.
    Whitington PF, Alonso EM, Millis JM.
    Transplant Proc; 1996 Aug; 28(4):2267-9. PubMed ID: 8769221
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Increased dosage requirement and rejection after Neoral conversion in pediatric liver transplant patients.
    Cao S, Cox KL, Berquist W, So S, Concepcion W, Monge H, Esquivel CO.
    Transplant Proc; 1998 Dec; 30(8):4322-4. PubMed ID: 9865373
    [No Abstract] [Full Text] [Related]

  • 11. Improvement of correlation between oral dose of cyclosporine and cyclosporinemia after substitution of cyclosporine standard presentation by cyclosporine microemulsion one, in 1345 patients with kidney transplantation. Spanish Sandimmune Neoral Conversion Group.
    Gentil Govantes MA, Gómez Ullate P, Errasti P, Fernández Fresnedo G, Capdevila L, Sanz Guajardo A, Cubero JJ.
    Transplant Proc; 1998 Aug; 30(5):1658-9. PubMed ID: 9723231
    [No Abstract] [Full Text] [Related]

  • 12. Reduced acute rejection and side effects with neoral in liver transplantation.
    Tisone G, Vennarecci G, Pisani F, Baiocchi L, Mercadante E, Orlando G, Anselmo A, Casciani CU.
    Transplant Proc; 1998 Jun; 30(4):1430-1. PubMed ID: 9636579
    [No Abstract] [Full Text] [Related]

  • 13. A critical appraisal of cyclosporine A pharmacokinetics in pediatric kidney transplantation using a microemulsion galenic formulation (Neoral).
    Foradori A, Pinto VM, Elberg A.
    Transplant Proc; 1998 Aug; 30(5):1666-7. PubMed ID: 9723235
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Successful reconversion from tacrolimus to cyclosporine A Neoral in pediatric liver recipients.
    Melter M, Rodeck B, Kardorff R, Hoyer PF, Maibücher A, Brodehl J.
    Transplant Proc; 1996 Aug; 28(4):2276-8. PubMed ID: 8769224
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Induction of immunosuppression by microemulsion cyclosporine in liver transplantation.
    Rasmussen A, Hjortrup A, Hansen B, Heslet L, Kirkegaard P.
    Transplantation; 1996 Oct 15; 62(7):1031-3. PubMed ID: 8878402
    [Abstract] [Full Text] [Related]

  • 18. Immunosuppressive therapy with microemulsion cyclosporine A shortens the hospitalization of pediatric liver transplant recipients.
    Arumugam R, Soriano HE, Scheimann AO, Reid BS, Gopalakrishna GS, Barakat O, Ozaki CF, Wood PR.
    Clin Transplant; 1998 Dec 15; 12(6):588-92. PubMed ID: 9850457
    [Abstract] [Full Text] [Related]

  • 19. Economic evaluation of Neoral versus Sandimmune maintenance therapy for de novo liver transplant patients: results from an International Randomized Controlled Trial. Milton Study Group.
    Peeters P, Kazek M, Abella I, Noble I.
    Transplant Proc; 1998 Aug 15; 30(5):1838-42. PubMed ID: 9723301
    [No Abstract] [Full Text] [Related]

  • 20. Conversion from cyclosporine to Neoral in pediatric recipients for kidney, liver, and heart transplantation.
    Holmberg C, Laine J, Jalanko H, Leijala M, Hoppu K.
    Transplant Proc; 1996 Aug 15; 28(4):2262-3. PubMed ID: 8769219
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.